GENUINE improvements: Ublituximab plus ibrutinib for CLLApril 21, 2021Leukemia, Myelodysplasia, TransplantationHematologyOncology
Low-calorie diet linked to improved chemo response in leukemiaApril 14, 2021OncologyLeukemia, Myelodysplasia, Transplantation
Cancer screening stopped by pandemic: Repercussions to come?April 8, 2021Lung CancerBreast CancerMixed TopicsGenitourinary CancerLymphoma & Plasma Cell DisordersLeukemia, Myelodysplasia, TransplantationMultiple Myeloma
VEXAS: A novel rheumatologic, hematologic syndrome that’s making wavesApril 7, 2021Leukemia, Myelodysplasia, TransplantationHematology
Poor survival with COVID in patients who have had HSCTMarch 26, 2021Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell Disorders
Don’t delay: Cancer patients need both doses of COVID vaccineMarch 15, 2021Multiple MyelomaAMLBreast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung Cancer
How has the pandemic affected rural and urban cancer patients?February 18, 2021Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
COVID-19 vaccination in cancer patients: NCCN outlines prioritiesFebruary 1, 2021Breast CancerGenitourinary CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, TransplantationLung CancerLymphoma & Plasma Cell DisordersMelanoma
Model predicts acute kidney injury in cancer patients a month in advanceFebruary 1, 2021Genitourinary CancerLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersLung CancerBreast Cancer
Experts offer roadmap for treating CLL during the pandemicDecember 23, 2020Leukemia, Myelodysplasia, Transplantation
Patients with lung and blood cancers most vulnerable to COVID-19December 10, 2020Lung CancerLeukemia, Myelodysplasia, Transplantation
Extended virus shedding after COVID-19 in some patients with cancerDecember 10, 2020Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple Myeloma
Black race linked to poorer survival in AMLDecember 10, 2020AMLLeukemia, Myelodysplasia, Transplantation
Fixed duration ibrutinib/venetoclax appears feasible for some CLL/SLL patientsDecember 6, 2020Leukemia, Myelodysplasia, TransplantationHematology
In MDS, transplant ups survival in elderly and may be reimbursedDecember 5, 2020Leukemia, Myelodysplasia, TransplantationHematology
